Dr. Rajiv (Raj) Dahiya holds an MD from the University of Missouri-Kansas City’s School of Medicine. He serves as a radiation oncologist at Premier Cancer Centers in Dallas, TX, and concurrently works with Predictive Medical Solutions, a state-of-the-art diagnostic testing service. Dr. Raj Dahiya is accomplished in minimally invasive therapies, including advanced radiation technologies.
In April 2017, researchers published findings from the recent Head Start III trial. This clinical trial evaluated the efficacy of treatments for pediatric patients with brain tumors that exposed them to minimal or no radiation. Some patients received standard radiation treatments as a control group, while a second group underwent high-dose chemotherapy and then a stem cell transfusion in lieu of radiation.
Radiation can be very harmful to children, especially very young children. Many parents and physicians have been reluctant to start pediatric patients on radiation because of its impact on brain development. However, the Head Start III trial suggests that radiation therapy leads to the best outcomes for pediatric patients. Those who did not receive radiation generally experienced worse outcomes, highlighting the importance of well-timed, well-dosed radiation treatments.
No comments:
Post a Comment